May Health, a clinical-stage medical device company dedicated to addressing polycystic ovary syndrome (PCOS), has announced the successful closure of a $25 million Series B financing round. The funding round was co-led by Bpifrance and Trill Impact Ventures, with participation from existing investor Sofinnova Partners, as well as Avestria Ventures and Kidron Capital Assets. PCOS affects approximately 10% of women globally, causing…
San Francisco-based healthcare platform Allara Health has released a study shedding light on the significant productivity loss experienced by individuals with Polycystic Ovary Syndrome (PCOS). Led by Dr. Heather Huddleston, MD, Director of the University of California San Francisco PCOS Clinic, the research aims to understand the professional impact of this chronic hormonal condition on women of reproductive age. Titled “Productivity loss…
This annual initiative is set to raise public awareness and contribute to bridging the gap about female hormonal health. Mira, a hormonal health company providing integrative care and hormonal testing for women, announced the first Sex Hormones Awareness Week in the U.S., set to take place from February 18th to February 24th, 2024. With this initiative, Mira seeks to educate people about their…
Roche Diagnostics has recently received CE-mark regulatory approval for a novel method of diagnosing Polycystic Ovary Syndrome (PCOS), a common endocrine disorder affecting approximately 1 in 8 women of reproductive age. The newly approved Elecsys Anti-Müllerian Hormone (AMH) Plus immunoassay, previously used in fertility diagnostics, now offers a non-invasive alternative to the traditional transvaginal ultrasound for diagnosing PCOS. PCOS, characterized by a…
OOVA, a women’s health platform specializing in remote hormone monitoring, has unveiled its new at-home Perimenopause Hormone Kit. The kit, unique in its approach according to the company, features urine-based multi-hormone biomarkers, including estrogen (E3G), and is complemented by an app that offers real-time data tracking. Differing from traditional blood or FSH-only urine tests, the OOVA kit enables a comprehensive 15-day hormone…
Metabolon, recognized for its contributions in metabolomics, has recently been awarded a grant by the National Institute of Health (NIH). This funding will go towards the development of a more accurate diagnostic test for polycystic ovary syndrome (PCOS). An estimated 8-13% of women are affected by PCOS, yet up to 70% remain undiagnosed. Metabolon’s project, backed by the NIH grant, seeks to…
Inito, the India-based health tech startup founded by Aayush Rai and Varun AV in 2015, has secured $6M in Series A funding led by Fireside Ventures. The fresh funds will go towards global expansion of Inito’s hormone testing solutions and will bolster research and development efforts for new diagnostic tests. Inito’s fertility monitor enables women to track fertility hormones quickly and conveniently…
Allara, a virtual care platform serving women of reproductive age with chronic hormonal conditions, has announced a $10M Series A funding round led by GV (Google Ventures). Participants in the funding round include Great Oaks Venture Capital, Humbition, Vanterra, Gaingels, and individual investors such as Tom Lee from One Medical and Maggie Sellers. Additionally, Frédérique Dame, GV’s General Partner, will join Allara’s…
